Nightingale has applied for its series B shares to be listed on Nasdaq First North Growth Market Finland and commences the initial public offering
Company Release 8 March 2021 at 9:05 Finnish time NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, NEW ZEALAND, AUSTRALIA, JAPAN, HONG KONG, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. Nightingale Health Plc (“Nightingale” or the “Company”) today announced that it has today filed a listing application with Nasdaq Helsinki Ltd for listing of the Company’s series B shares on Nasdaq First North Growth Market Finland maintained by Nasdaq Helsinki Ltd (“First North